Version française | English Version

logo-SIRIC-ILIAD-horizontal-4000

For the 2nd time in a row, the ILIAD project is labeled SIRIC for 5 years! Supported by Nantes University Hospital, Angers University Hospital & Western Cancer Institute (ICO), the renewal of SIRIC ILIAD by the National Cancer Institute (INCa) is proof of the excellence of the Nantes-Angers research site , integrating medical, scientific & social research in breast cancer and multiple myeloma.

For the next 5 years, SIRIC ILIAD’s mission will be to conduct high-level multidisciplinary research, thanks to the know-how of the project partners: Universities, health establishments, associations, engineering schools, research laboratories including CRCI2NA and Arronax members of Labex IRON.

Ultimately, the objectives are to succeed in increasing remission and recovery for patients, and to raise awareness among professionals to include and adapt the professional life of patients with cancer.